Ray Dalio's LGND Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 9,763 shares of Ligand Pharmaceuticals Incorporated (LGND) worth $3.05 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Ray Dalio has maintained this position in LGND for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 9,763 shares. Largest reduction occurred in Q1 2026, reducing 4,207 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Ligand Pharmaceuticals Incorporated (LGND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ligand Pharmaceuticals Incorporated (LGND) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +9,763 | New Buy | 9,763 | $312.37 |
| Q1 2026 | -4,207 | Sold Out | 0 | $0.00 |
| Q4 2025 | +2,919 | Add 226.63% | 4,207 | $189.07 |
| Q3 2025 | +1,288 | New Buy | 1,288 | $177.14 |
Ray Dalio's Ligand Pharmaceuticals Incorporated Investment FAQs
Ray Dalio first purchased Ligand Pharmaceuticals Incorporated (LGND) in Q3 2025, acquiring 1,288 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Ligand Pharmaceuticals Incorporated (LGND) for 4 quarters since Q3 2025.
Ray Dalio's largest addition to Ligand Pharmaceuticals Incorporated (LGND) was in Q3 2026, adding 9,763 shares worth $3.05 M.
According to the latest 13F filing for Q3 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 9,763 shares of Ligand Pharmaceuticals Incorporated (LGND), valued at approximately $3.05 M.
As of the Q3 2026 filing, Ligand Pharmaceuticals Incorporated (LGND) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Ligand Pharmaceuticals Incorporated (LGND) was 9,763 shares, as reported at the end of Q3 2026.